摘要:
The invention relates to substituted oxopyridine derivatives and methods for the production thereof, as well as to the use thereof in the production of medicinal drugs for treating and/or preventing diseases, especially diseases of the cardiovascular system, preferably thrombotic or thromboembolic diseases, as well as oedemas, and also ophthalmological diseases. The oxopyridine derivatives inhibit factor XIa and plasma kallicrein.
摘要:
The invention relates to substituted oxopyridine derivatives of the formula in which R 1 is a group of the formula, where * is the attachment site to the oxopyridine ring, R 6 is bromine, chlorine, fluorine, methyl, difluoromethyl, trifluoromethyl, methoxy, difluoromethoxy or trifluoromethoxy, R 7 is bromine, chlorine, fluorine, cyano, nitro, hydroxyl, methyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, difluoromethoxy, trifluoromethoxy, ethynyl, 3,3,3-trifluoroprop-l-yn-l-yl or cyclopropyl, and to processes for preparation thereof and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular diseases, preferably thrombotic or thromboembolic diseases and of oedemas, and also of ophthalmological disorders.
摘要:
The invention relates to novel substituted bipiperidinyl derivatives, to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of diabetic microangiopathies, diabetic ulcers on the extremities, especially for promotion of wound healing of diabetic foot ulcers, diabetic heart failure, diabetic coronary microvascular heart disorders, peripheral and cardiac vascular disorders, thromboembolic disorders and ischaemias, peripheral circulation disorders, Raynaud phenomena, CREST syndrome, microcirculation disorders, intermittent claudication, and peripheral and autonomous neuropathies.
摘要:
The invention relates to novel (3-hydroxyphenyl)amino-substituted pyrido[2,3- b ]-[1,5]benzodiazepine-5-one-derivatives, to methods for the production thereof, use thereof alone or in combination for treating and/or for preventing diseases and use thereof in producing medicaments for treating and/or preventing diseases, especially angiogenic disorders and hyperproliferative disorders with a neovascularization component, such as opthalmologic disorders such as cancers and tumor diseases. Such treatments can be carried out as monotherapy or also in combination with other medicaments or additional therapeutic measures.
摘要:
This invention relates to novel 5-[(hydroxymethyl)aryl] -substituted pyrrolo[2, 1-f][1, 2, 4] triazin-4-amines of formula (I), to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for treating angiogenesis-related disorders, in particular angiogenesis-related ocular disorders.